Statin-Associated Myopathy with Normal Creatine Kinase Levels

Josh Torgovnick; Edward Arsura

doi:10.7326/0003-4819-138-12-200306170-00021

Letters |17 June 2003

Statin-Associated Myopathy with Normal Creatine Kinase Levels

Josh Torgovnick, MD; Edward Arsura, MD

Article, Author, and Disclosure Information

TO THE EDITOR:

We read with interest the article by Phillips and colleagues (1) and the accompanying editorial (2). One of us (Dr. Torgovnick) developed low-grade myopathy while receiving statin therapy. Atorvastatin, 5 mg (0.5 tablet), was started in September 1999. Nonspecific aches and pains were noticed, but no clear weakness was evident and Dr. Torgovnick continued regular exercise. On several occasions, a burning sensation beyond what was anticipated developed in the muscles after exercise. Low-grade myopathy was considered in June 2000, and creatine kinase level was checked. The result, 3.14 kat/L, was normal (reference range, 0 to 3.34 kat/L), and atorvastatin therapy was continued.

FULL TEXT

PDF

Not Available

2003 American College of Physicians

Letters |17 June 2003

Statin-Associated Myopathy with Normal Creatine Kinase Levels

See Also

Content

Information For

Services

Awards

Other Resources

Follow Annals On

Letters |17 June 2003

Statin-Associated Myopathy with Normal Creatine Kinase Levels

See Also

Content

Information For

Services

Awards

Other Resources

Follow Annals On

You need a subscription to this content to use this feature.